Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

L-asparaginase encapsulated in erythrocytes

EU orphan designation number: EU/3/13/1106   
Active ingredient: L-asparaginase encapsulated in erythrocytes
Indication: Treatment of acute myeloid leukaemia
Sponsor: ERYtech Pharma S.A.
60 avenue Rockefeller, Bâtiment Adenine, 69008 Lyon, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/02/2013 Orphan designation EMA/OD/167/12 (2013)807 of 08/02/2013